We are live on ! Find out more
BLFS icon

BioLife Solutions

164 hedge funds and large institutions have $797M invested in BioLife Solutions in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 43 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 43

0.38% more ownership

Funds ownership: 84.06%84.44% (+0.38%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 169164 (-5)

12% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 34

39% less capital invested

Capital invested by funds: $1.31B → $797M (-$508M)

84% less call options, than puts

Call options by funds: $180K | Put options by funds: $1.12M

Holders
164
Holders Change
-5
Holders Change %
-2.96%
% of All Funds
2.59%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
72
Reduced
43
Closed
34
Calls
$180K
Puts
$1.12M
Net Calls
-$937K
Net Calls Change
+$1.55M
Name Holding Trade Value Shares
Change
Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$1.38M +$475K +18,054 +43%
Swiss National Bank
52
Swiss National Bank
Switzerland
$1.34M +$147K +5,600 +10%
CCA
53
Conestoga Capital Advisors
Pennsylvania
$1.3M +$149K +5,655 +11%
BA
54
Bridgewater Associates
Connecticut
$1.27M +$344K +13,058 +30%
Public Sector Pension Investment Board (PSP Investments)
55
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.27M -$98.2K -3,730 -6%
MPAM
56
Monarch Partners Asset Management
Massachusetts
$1.25M
IP
57
Isthmus Partners
Wisconsin
$1.17M +$622K +23,608 +85%
Dimensional Fund Advisors
58
Dimensional Fund Advisors
Texas
$1.14M -$1.12M -42,591 -46%
SEI Investments
59
SEI Investments
Pennsylvania
$1.13M +$21.5K +817 +2%
PBO
60
Peoples Bank (Ohio)
Ohio
$1.11M +$41.3K +1,567 +3%
PM
61
Penbrook Management
New York
$1.1M
MIM
62
Meros Investment Management
Texas
$1.1M +$606K +23,009 +90%
Envestnet Asset Management
63
Envestnet Asset Management
Illinois
$1.05M +$299K +11,374 +33%
US Bancorp
64
US Bancorp
Minnesota
$1.02M -$15.8K -600 -1%
CSS
65
Cubist Systematic Strategies
Connecticut
$1.02M +$1.18M +44,686 New
First Trust Advisors
66
First Trust Advisors
Illinois
$874K -$356K -13,536 -26%
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$823K -$418K -15,874 -30%
Royal Bank of Canada
68
Royal Bank of Canada
Ontario, Canada
$779K +$237K +8,986 +35%
SI
69
Stephens Inc
Arkansas
$771K +$521K +19,793 +140%
Mirae Asset Global Investments
70
Mirae Asset Global Investments
South Korea
$750K +$868K +32,989 New
UBS AM
71
UBS AM
Illinois
$707K
Prudential Financial
72
Prudential Financial
New Jersey
$693K -$781K -29,651 -49%
Los Angeles Capital Management
73
Los Angeles Capital Management
California
$685K +$794K +30,150 New
KCM
74
Kornitzer Capital Management
Kansas
$655K +$758K +28,800 New
JF
75
Jump Financial
Illinois
$650K +$752K +28,567 New

BLFS Hedge Fund Activity: Q1 2022 in Review

164 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2022, worth a combined $797M — down 39% from $1.31B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of BLFS and 30 opened new positions — a net loss of 4 holders — while 43 trimmed existing stakes and 72 added.

The largest buyer was Millennium Management, adding an estimated $14.1M. The largest seller was Marshall Wace, cutting an estimated $12.1M.

  • 164 institutional investors held BioLife Solutions (BLFS) as of Q1 2022, down from 169 in Q4 2021.
  • Funds reported $797M of BioLife Solutions stock for Q1 2022, down 39% quarter-over-quarter.
  • 30 funds opened new BioLife Solutions positions in Q1 2022 and 34 closed out, a net change of -4 holders.
  • The largest BioLife Solutions buyer in Q1 2022 was Millennium Management, an estimated $14.1M added.
  • The largest BioLife Solutions seller in Q1 2022 was Marshall Wace, an estimated $12.1M sold.

Based on aggregated 13F filings for Q1 2022.